Biotech, pharmaceutical and medical device developers, as well as the lawyers who represent them, gathered recently at a Kentucky Derby party in Plymouth Meeting. Amid the games, faux betting, and interesting displays of new genetic technologies and services, I talked with researchers and chief executive officers about some fascinating projects underway. It didn’t seem like […]
Read More… from Op-Ed: Why Bio-Tech and Pharma C-Suites Should Understand Sunshine Laws